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Granulocytes, to  escape  from the  blood stream,  must presumably adhere  to  the 
vascular wall before they enter the tissue by diapedesis and chemotaxis. Although such 
adherence  seems essential to the early inflammatory process, the accumulated knowl- 
edge concerning the mechanisms of  leukocyte emigration concentrates predominantly on 
motility and chemotaxis (1-3); the process of adherence of leukocytes to the endothelial 
surface has been less well defined and generally only at the level of light and electron 
microscopy (2, 4). Investigations utilizing transparent vessels in living animals indicate 
that leukocyte adhesion without emigration may be the only inflammatory  reaction after 
minimal tissue damage - an observation clearly separating the process of  adherence from 
chemotaxis.  Moreover, the finding that temporary leukocyte attractions to undamaged 
endothelial walls occur regularly (4) suggests that adherence may also play an as yet 
undefined role in normal vascular physiology. 
Since the development of methods of labeling blood granulocytes as with 
DF32p, the existence of so-called marginated neutrophils (5), representing about 
one-half of all intravascular granulocytes, has become apparent.  These cells 
exchange rapidly with freely circulating ones. An attractive hypothesis is that 
margination is  a  function of cell stickiness. In the present studies we have 
investigated this possibility by studying a  situation in which profound neutro- 
penia due to excessive margination occurs-the transient neutroponia which 
occurs in donors undergoing continuous flow filtration leukophoresis  (CFFL) 
(6).1 This neutropenia is virtually identical to that noted in uremic patients at 
the beginning of hemodialysis-  another extracorporeal perfusion system (7, 8). 
In the latter situation, we have recently demonstrated that almost the total 
* Supported in part by grants AM15730/HL19752 from the National Institutes of Health, U. S. 
Public Health Service; presented in part as a preliminary report at the third meeting of the 
International Society of Hematology, European and African Division, London. August 1975. 
Abstract no. 16: 18. 
1  Abbreviations  used in this paper: AGG, aggregated gamma globulin; C, complement;  CFFL, 
continuous flow  filtration leukophoresis; CVF, cobra venom factor; EDTA, ethylenediaminetet- 
raacetic acid; HBSS, Hank's balanced salt solution; MPO, myeloperoxidase;  NF, nylon  fibers; 
PBS, phosphate-buffered  saline. 
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circulating granulocyte pool transiently sequesters in the lung (9), and does so 
in response  to  the  infusion of complement  (C)  components  activated  by  the 
dialysis  coil cellophane  (10).  This has suggested to us that margination may 
somehow involve C-induced granulocyte adhesiveness. In the present studies we 
provide  supportive  evidence  that  the  C  system  may  play  a  central  role  in 
granulocyte  adherence and,  moreover,  that granulocyte margination in vivo, 
and adhesiveness assayed in vitro, are closely related phenomena. 
Materials and Methods 
Human Studies.  CFFL was performed as previously described  (11). Blood cell counts were 
done on ethylenediaminetetraacetic acid (EDTA)-anti-coagulated samples drawn from the out- 
line proximal to the filter system. Erythrocyte and leukocyte counts were done on a Coulter model 
S Counter (Coulter Electronics, Inc., Hialeah, Fla.) and differential counts were obtained from 
Wright-stained  slides.  Platelets were counted directly by phase  contrast microscopy  by using 
procaine HC1, 3.5 g per 100 ml, as a diluent. 
Rabbit Studies.  Pentothal-anesthesizod male and female New Zealand White rabbits weigh- 
ing 2.5--4.0 kg were prepared with sterile polyethylene cannulae in femoral or jugular veins for the 
infusion of plasma or other agents, and in femoral or carotid arteries for blood sampling. Fresh 
autologous cell-free plasma was obtained by collecting 35 ml blood into ice-coolod plastic syringes; 
after transfer into precooled plastic tubes and centrifugation at 4°C for 7 rain at 20,000 g, the 
supernatant plasma was immediately decanted and anti-coagulated with 3 U/ml sodium heparin 
(Upjohn Co., Kalamazoo, Mich.).  20 ml of such plasma was incubated in a sterile polystyrene tube 
with 1 g of nylon fibers (NF) from a Fenwal filtration leukophoresis set system (Fenwal Laborato- 
ries, Inc., Morton Grove, Ill.) or with other specified agents; aiter removal of the perturbant, the 
activated plasma was reinfused over a 2-rain period. Blood for leukocyte and differential counts 
was sampled at various intervals thereafter. 
Complements Assays and Immunoreactants.  Total complement (CH50) and C1 and C3 activi- 
ties were assayed by standard  hemolytic assays  (12). Radial immunodiffusion, performed with 
commercial plates (Cordis  Laboratories,  Miami, Fla.), was also used to assay C3.  Anticomple- 
mentary cobra venom factor (CVF) was isolated from lyophilized Naja naja cobra venom (Ross 
Allen's  Reptile  Institute,  Inc.,  Silver Springs,  Fla.)  by  diethylaminoethyl-cellulose column 
chromatography  (13). Complement depletion in  approximately 4-kg  rabbits  was  produced  by 
injecting intravenously 700 U of CVF 24 and again 12 h before experimental manipulation (13). 
Zyrnosan  (Sigma Chemical Co., St. Louis, Mo.) in 0.9% saline was kept in a boiling waterbath for 
30 rain, washed twice, and resuspended at 50 mg/ml in phosphate-buffered saline (PBS) of pH 7.4 
containing 1 mM magnesium. Plasma was activated by incubation for 30 rain at 37°C with 5 mg 
zymosan/ml, followed by removal of zymosan by sedimentation at 20,000 g  for 10 vain.  Inulin 
(Sigma Chemical Co.), at the same concentration, was sonicated instead of boiled and then used 
identically as  zymosan. Aggregated gamma globulin (AGG) was prepared by diluting human 
gamma globulin (Swiss Red Cross,  Berne, Switzerland) in PBS, pH 7.4, at a concentration of 50 
mg/ml, heating at 63°C for 30 mill, and washing the precipitate twice in PBS. The final concentra- 
tion used to activate the C system in plasma was 5 mg/ml. 
Hydrazine Treatment of  Plasma.  A 200-ram solution of hydrazine (Fisher Scientific Co., Fair 
Lawn, N. J.), freshly prepared in saline ofpH corrected to 7.5 with 2 N HC1, was added to plasma 
to yield a final concentration of 10 mM hydrazine, and then incubated in a tumbling tube for 30 
rain at 37°C. Subsequently, the plasma was dialyzed at 4°C for 2 h against PBS, pH 7.4, and for 20 
rain against Hank's balanced salt solution (HBSS) before use. 
Ultrafiltration  of Activated  Serum.  Ultrafiltration  membranes  (Diaflo)  and  magnetically 
stirred cells from Amicon Corp., Scientific System Div., Lexington, Mass.,  were used.  Serum, 
chosen to avoid precipitation of fibrinogen on the membranes, was prepared from cell-free plasma 
by immediate centrifugation of rabbit whole blood at 4°C for 6 rain, followed by incubation at room 
temperature for 30 min and a further 45 rain at 4°C. 20 ml serum incubated for 30 rain with 1 g of 
NF at 37°C was subsequently ultrafiltrated with different membranes at 4°C. With membranes of 
tool wt cutoff limits lower than 50,000, repeated filtration and redilution with PBS, pH 7.4, was JORG  FEHR  AND  HARRY  S.  JACOB  643 
found to be essential. The filtrates,  after concentration by a UM 2 membrane (mol wt cutoff limit 
1,000), were injected in a volume of 18-20 ml to mimic the experiments with neat plasma. 
Granulocyte Adherence Assay.  Leukocyte suspensions, prepared by our previously described 
technique  (9, 10) were washed twice in HBSS (Microbiological Associates, Bethesda,  Md.), and 
resuspended in HBSS at 4 × 106 granulocytes/ml. For quantitation  of adherence to duplicate Petri 
dishes (Falcon Plastics, Division of BioQuest, Oxnard, Calif.; tissue culture dish 3,001), 2.5 ml of 
the granulocyte  suspension was pelleted and then resuspended in 2.5 ml of autologous plasma 
which had been treated in a variety of ways (e.g. heat-inactivated,  fresh, inulin-activated  etc.). 
After incubation  for 5 min at 37°C, two 1-ml-samples were transferred  into the duplicate Petri 
dishes which were incubated  at 37°C for 30 min in a water-jacketed  CO2-incubator and subse- 
quently washed in a sequence of six beakers with 0.9% saline and dried for 2 h in a refrigerator. 
The myeloperoxidase (MPO) content of  adherent cells of each dish was extracted into 1 ml of 1.5 M 
NaC1 (14) containing 0.5% Triton X-100 (Calbiechem, San Diego, Calif.) by freeze-thawing four 
times.  The extraction  fluid was assayed for MPO activity  by the technique  of Lundquist  and 
Josefsson  (15). This  assay  showed a  linear  relationship  between the number of granulecytes 
assayed and the initial  velocity of the enzyme activity between 1 × 10  ~  and 30 × 104 cells. Thus, 
appropriate  dilutions  of the experimental  samples were made to encompass this range.  Pure 
plasma  (90-100%) was chosen as suspension medium representing  the most physiologic milieu, 
and because diluting the plasma from 80 to 25% resulted in a progressively decreasing adherence 
of cells, possibly revealing  physiologic inhibitors,  a finding which has been reported for chemo- 
taxis  (16). Below 25% plasma  concentration,  an unspecific protein-dependent  increment  in cell 
adherence was found. The sensitivity  of the MPO method is in the range of 0.5 ng purified horse 
radish peroxidase and the activity of  50 ng of  this peroxidase corresponded to the activity extracted 
from 1 × 10  s granulecytes. By knowledge of  the number of  cells put on dishes and their initial MPO 
activity, the absolute number of adherent cells remaining after washing could be determined. The 
variability  of the MPO assay was less than 3% and the variability  between duplicate dishes less 
than 6%. 
Results 
The  Transient Leukopenia of CFFL.  The sequence of leukocyte counts in 
four normal donors undergoing CFFL confirms recent observations by others 
(6),  in that a parallel drop of neutrophils and monocytes occurs within 5-10 min 
after onset of the procedure (Fig. 1). Shortly thereafter, rebound granulocytosis 
with an increase in band forms occurs while monocytes return more sluggishly. 
Lymphocytes and  thrombocyte  counts  do  not  significantly  change,  and  the 
results correspond exactly with previously reported ones in patients undergoing 
hemodialysis (8-10). 
Characterization of the Mediator of  NF-Induced Neutropenia in Rabbits.  By 
analogy to  our  studies  in hemodialysis neutropenia  (10),  the  possibility was 
analyzed that C  activation by the NF of the filter system might be responsible 
for the profound changes in neutrophil kinetics. As shown in Table I, when 18- 
20 ml autologous plasma was incubated with NF at 37°C for 30 rain and rein- 
fused into rabbits over 2 min,  a  precipitous fall of circulating granulocytes to 
nearly zero was always observed; cells returned to circulation within 20-30 rain, 
but only after the infusion was stopped. Continuing the infusion resulted in pro- 
longed neutropenia, and repeated injections over a short time produced identical 
episodes  of granulocytopenia.  There  was  no  difference  in  the  reaction if un- 
treated  NF or those boiled and washed for prolonged periods  were used.  The 
temperature at which NF/plasma incubation was performed also did not seem 
critical,  as  22°C  incubations  produced identical  neutropenia  to  that  noted  at 
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TABLE  I 
Characterization  of the Granulocytopenia-Inducing  Factor in Rabbit 
Treatment of  or 
addition to 
plasma before  NF 
incubation 
Circulating granulocytes after  injection  of  NF-incubated plasma 
(percent  of  initial  level) 
0 rain  2.5 rain  5 rain  10 rain  20 min  60 rain 
Untreated (37°C)  4  100  0,5  -+- 0,5  3  -  2  47  _+  13  83 -+ 13  136  -  17 
Untreated (22°C)  2  100  0  4  -+  1  43  ___  5  150  --,  30  140  _+  20 
56°C 30 min  4  100  89  -+  3  96  -+  7  104  +  9  100  --  4  103  ---  12 
50°C 30 min  2  100  1  -+  0.5  0  16  -+  5  90  ---  15  150  ---  20 
EDTA,  10 mM  3  100  88  _+ 4  84  _+  6  94  ---  8  97  ---  10  120  -+  10 
Results are means and -+ SD, or means and range when less  than three experiments were done. 
Duration of  incubation of  plasma with NF: 30  rain  37°C,  except where otherwise stated.  Amount of 
plasma injected:  18-20 ml. 
In ancillary studies (not shown) human plasma, incubated in vitro with NF at 
37°C for 30 min, lost only 10% of total hemolytic complement, 25% of  C1, and 15% 
of C3 (although C3 levels were not detectably altered when assayed by radial 
immunodiffusion). The same parameters monitored in human donors undergo- 
ing  CFFL  also  were  not  unequivocally  or  consistently  altered.  Since  these 
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and the transient leukocyte sequestration process, indirect ways were chosen to 
validate such an association. Thus, prevention of C activation by chelation of 
Ca  ++ and Mg  ++ with EDTA was found to block the neutropenic response (Table 
I). Moreover, heat (56°C) inactivation of rabbit plasma before NF exposure also 
prevented the neutropenia. In contrast, preheating plasma at 50°C, a procedure 
which blocks the alternative pathway of C  activation by destroying C3 pro- 
activator, but which spares the enzyme activities of the classical pathway (17, 
18), was not inhibitory, hut even slightly prolonged the neutropenic response. 
Recombination experiments (19, 20) also supported the proposition that C ac- 
tivation underlies NF induction of neutropenia (Fig.  2).  Thus,  neither heat- 
inactivated plasma (56°C, 30 min), which lacks Clr, C2, and C3 proactivator ac- 
tivity (21) nor hydrazine-treated plasma, which lacks C4 and C3 activity (18, 
22)  produced the neutropenic response after activation with NF.  However if 
these plasmas were mixed in equal parts before NF incubation, which recon- 
stitutes C3 activability, neutropenia-inducing potential was restored. That acti- 
vated  C  components underlie  CFFL  neutropenia was  further  supported by 
studies in CVF-treated, C-depleted animals. That is, plasma of a depleted ani- 
mal, when incubated with NF, does not cause neutropenia, although normal 
plasma induces profound neutropenia when infused into the C-depleted rabbit 
(not shown). Moreover,  reinfusion of autologous rabbit plasma in which the 
classical pathway of C is activated in vitro by AGG (23) produces- after removal 
of the activator by high speed centrifugation-decrements of circulating neu- 
trophils identical to that of CFFL; neutrophils remained below 10% of base line 
during the first 10 min, 43% at 20 min, and returned to 115% at 60 rain. In addi- 
tion, if C is activated in vivo in 2.5-kg rabbits by intravenous injection of 200 mg 
AGG (classical pathway activation) or by infusion of 700 U CVF (alternative 
pathway activation [24]), immediate neutropenia with circulating cells falling 
below 10% during the first 25 rain is provoked. 
An  attempt  to  further  characterize  the  neutropenia-inducing molecule(s) 
generated by the NF incubation was made by utilizing ultrafiltration through 
membranes of standardized pore size (Table II). Thus, the neutropenia factor 
was found to pass a membrane with a mol wt cutoff at 30,000, but was retained 
by a membrane with a cutoff at 10,000. 
Granulocyte  Adherence  In  Vitro  and  Its  Dependence  on  Complement.  As 
assayed by retained myeloperoxidase activity, granulocytes adhere in signifi- 
cant numbers to plastic Petri dishes when suspended in fresh plasma.  When 
plasma is heat-inactivated at 56°C for 30 min, granulocyte adhesion is reduced 
significantly as shown in 10 such experiments. Thus, 7 _+ 3% (SD) of surface- 
exposed cells adhere when suspended in heat-inactivated plasma, compared to 
19 _+ 4% when in fresh plasma (P <  0.001). Since these findings suggested the 
possible involvement of C components in in vitro granulocyte adherence, recon- 
stitution techniques similar to those used for the characterization of the neutro- 
penia-inducing factor of CFFL were undertaken (Fig. 3). Hydrazine treatment 
of  plasma reduced the adherence-promoting  capacity of fresh plasma to a similar 
extent to  that  of heat inactivation.  However,  adherence-promoting capacity 
was, at least partly, restored by mixing hydrazine and heated plasmas together. 
A similar restoration was obtained by adding purified C3 (Cordis Laboratories, 646  COMPLEMENT  ROLE IN  GRANULOCYTE  ADHERENCE  AND  MARGINATION 
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FIG. 2.  Complement dependence of NF-induced neutropenia: recombination experiments 
in rabbits.  O--O fresh plasma; •  .....  •  heated plasma (56°C);  A...•  hydrazine-treated 
plasma; O--© equal amounts of heated and hydrazine-treated plasmas. Means and range of 
triplicate experiments. 
TABLE  II 
Partial Separation of Neutropenia-Inducing Substance by Ultrafiltration of Rabbit NF- 
Activated Serum 
Ultrafiltration membrane* 
(mol wt cutoff limit) 
Circulating granulocytes after injection of ultrafiltrate 
(percent of initial level) 
0 min  1.5 min  4 min  10 min 
%  %  %  % 
XM300  (300, 000)  100  2  10  52 
XM100  (100, 000)  100  27  26  61 
PM30$  (30, 000)  100  1.3  10  61 
PM10$  (10, 000)  100  90  78  77 
Results are means of two experiments; the range did not exceed 6%. 
* Diaflo, Amicon Corp. 
$ Repeated redilution and filtration with five times the original serum volume. 
Miami, Fla.),  200 U/ml, m hydrazine-treated plasma; in two experiments this 
component doubled the amount of cells from 23-24% (range of two experiments) 
in hydrazine-treated plasma to 48-56% in the same plasma to which was added 
purified C3  (not shown).  Moreover,  granulocyte adherence was strikingly  in- 
creased when cells were suspended in plasmas in which the C system was in- 
tentionally activated. Thus, activation of the alternative pathway of C by inulin 
and zymosan (Fig. 4, right part)  or CVF (not shown) roughly doubled cell ad- 
herence. 
To  determine  whether  the  effect of the  C-derived  granulocyte  adherence- 
promoting factor was reversible, cells were exposed for 5 min at 37°C to plasma 
activated with zymosan  (top,  Fig.  4) or inulin  (bottom,  Fig.  4) and after the 
removal of  the activated plasma by centrifugation at 4°C, they were resuspended JORG  FEHR  AND  HARRY  S.  JACOB  647 
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of fresh plasma  is taken  as 100%.  Bars  denote  mean  and  range  of twicely repeated 
experiments in two different  individuals (A +  B). F, fresh  plasma;  HI, heat-inactivated 
plasma  (56°C, 30 min); HY, hydrazine-treated  plasma; H  +  H, recombination  of equal 
amounts of  HI and HY plasmas. 
in prewarmed untreated plasma. At various times thereafter a  1-ml sample of 
this suspension was removed to duplicate Petri dishes and granulocyte adher- 
ence assayed. When resuspended in fresh plasma at 37°C, cells progressively  lost 
their  increased  stickiness  between  15  and  20  min  and  then  maintained a 
constant adhesiveness (at the level of fresh plasma adherence) over the next 45- 
60 min (Fig.  4,  solid symbols). In contrast, when resuspended in heat-inacti- 
vated (56°C, 30 min) plasma, no significant decrease in the intense cell adhesive- 
ness was noted (bottom, Fig. 4, open symbols). 
Discussion 
To study mechanisms regulating the distribution of intravascular granulo- 
cytes between circulating and marginated pools, we took advantage of a human 
model with extreme transient margination, the neutropenia of CFFL (6). The 
early profound transient neutropenia, which has been noted by others during 
the procedure, was confirmed, and additionally we documented that monocytes 
decreased as well. Moreover, we showed that simple exposure of plasma to NF 
produces, upon reinfusion, the neutropenic response. In analyzing C involve- 
ment in this transient sequestration process, it became evident that routine 
laboratory assays which measure C consumption were not sensitive enough to 
document a  role for C. In contrast, by utilizing our infused rabbit model, we 
could demonstrate that a complement-derived  granulocytopenia-inducing  factor 648  COMPLEMENT  ROLE  IN  GRANULOCYTE  ADHERENCE  AND  MARGINATION 
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FIG. 4.  Reversibleeffect°fthec°mplement'derivedadherence'pr°m°tingfactor°ngranu" 
locytes in fresh plasma and sustained effect in heat-inactivated plasma. A--A cells briefly 
exposed to zymosan-activated plasma and kept in fresh plasma; Q--Q cells briefly exposed 
to inulin-activated plasma and kept in fresh plasma; O--O cells briefly exposed to inulin- 
activated plasma and kept in heat-inactivated (56°C, 30 rain) plasma.  Bars on the right 
denote cell adherence in heat-inactivated (HI), fresh (F), and activated (ZA, zyrnosan,  IA, 
inulin) plasma, respectively, without preexposure to C-activated plasma (mean _+ SD; n  for 
HI, F, and ZA ffi 10; n for IA = 3). Differences between HI and F, F and ZA, F and IA are 
statistically significant (P <  0.001, Student's t test). Each point represents the mean value 
of duplicate Petri dishes, and the experiments were repeated twice with similar results. 
is generated by exposing plasma to NF. Whether NF activate predominantly the 
classical  or the alternative  pathway of C cannot be stated with certainty.  If 
C3PA of rabbits has the same exquisite heat lability at 50°C as documented for 
human and guinea pig C3PA (17, 18, 25), the continued induction ofneutropenia JORG  FEHR  AND  HARRY  S.  JACOB  649 
by NF-treated plasma which had been preheated at 50°C (Table I) indicates that 
activation of the classical pathway, at least partially, underlies CFFL neutro- 
penia. Nevertheless, C induction of  neutropenia is evidently not solely restricted 
to activation through the classical pathway, since activators both of  the classical 
pathway, for instance AGG (23, 26), as well as the alternative pathway, as CVF 
(24), produced neutropenia identical to that provoked by incubation with NF. In 
any  case,  our  recombination experiments with  hydrazine-treated  and  heat- 
inactivated plasmas,  combined with the demonstrated abolishing effect of C 
depletion in animals with CVF, strongly suggest an absolute requirement for C3 
in the NF induction of neutropenia-generating activity, since C3 is the common 
convergence point for these experimental systems. The mechanism by which NF 
activates C3 and possibly later components remains to be determined. The role 
for Hageman factor, a  known contact-activated component of the coagulation 
and kinin systems (27, 28) is suspected and is currently under investigation. 
Our ultrafiltration studies indicate that the NF-provoked neutropenia-induc- 
ing factor has a mol wt in the range of 10,000-30,000.  The prime candidates of 
known C split products with such small molecular weights, but high biologic 
activity (27, 29), are C3a and C5a (30) with their mol wt of 9,000 (31) and 17,500 
(32), respectively. Taking into account that protein admixture raises the cutoff 
limit of these ultrafiltration membranes (33), it can be assumed that both C3a 
and C5a are retained by the PM 10 membrane. In this regard, it has recently 
been proposed that the acute disappearance of granulecytes after intravascular 
activation of the C system may be the consequence of neutrophil and monocyte 
margination at sites of increased vascular permeability, caused by the anaphy- 
latoxin activity of C3a and C5a (34). However, we doubt this interpretation has 
validity in our studies since the neutropenia-inducing  factor generated by NF in 
vitro  maintains  its  activity  in  neat  plasma  for  hours  while  anaphylatoxin 
activity is rapidly destroyed by an anaphylatoxin inactivator (35). Moreover, in 
our previous studies (9), injection of C-activated plasma into neutropenic sheep 
produced no alteration of intravascular blood pressures and no indication of 
increased  vascular  permeability,  suggesting that  such  plasma  is  devoid of 
anaphylatoxin activity and that it is similar to the more stable chemotactic 
activities of C3a and C5a (35, 36). 
Possible mechanisms by which activated C components might produce neutro- 
penia have been considered; we favor the hypothesis that neutropenia results 
from  C-induced,  increased cell  adhesiveness to  endothelial surfaces.  To our 
knowledge, the influence of C on granulocyte adherence has not been studied 
systematically. A few indirect indications that C activation might play a role in 
leukocytes adhesiveness had been noted. Thus: (a) in transparent ear vessels of 
rabbits  sensitized to  horse  serum,  leukocytes adhere  to  vessel walls  during 
antigenic serum infusion (37); and (b) decomplemented  rabbits maintain consid- 
erably higher circulating granulocyte counts than normal ones (38) which might 
be a consequence of demargination. 
The high degree of association between in vivo margination and Petri dish 
adhesiveness demonstrated in the present studies suggests the two processes in 
fact reflect a common membrane-perturbing effect of C on granulocytes. In this 
regard it has recently been shown that exposure of granulocytes to C5a de- 
creases their net negative surface charge (39), engendering the suggestion that 650  COMPLEMENT  ROLE IN  GRANULOCYTE ADHERENCE  AND  MARGINATION 
adhesion occurs when powerful electrostatic repulsive forces between cells and 
substrate  (endothelium or plastic  dishes)  are  overcome, thereby permitting 
short range forces (Van der Waals and hydrophobic) to act (40, 41). Finally our 
results demonstrating partial reversibility of C-derived adherence in vitro (Fig. 
4) coupled with the reversibility of neutropenia in vivo permits the postulate 
that a heat-labile C-inactivating system in the circulation is responsible for the 
fact that granulocytes demarginate so quickly after the neutropenia-inducing 
stimulus has been withdrawn. This postulate is currently under active investi- 
gation. 
Summary 
To study mechanisms and mediators regulating the distribution of intravas- 
cular granulocytes between circulating and marginated pools, a human model 
with extreme transient margination, the neutropenia of continuous flow filtra- 
tion leukophoresis, was analyzed.  Studies in animals demonstrated the exis- 
tence  of a  complement (C)-derived  granulocytopenia-inducing factor.  Thus, 
autologous plasma, exposed to nylon fibers (NF) of the filtration system, pro- 
duced an acute selective decrement of circulating granulocytes and monocytes. 
This phenomenon  was blocked by decomplementing  plasma, by pretreatment of 
plasma with EDTA or hydrazine, and by preheating at 56°C, but did occur after 
recombination of heat-inactivated  and  hydrazine-treated  plasma before  NF 
exposure. Preheating plasma at 50°C did not inhibit the neutropenic response, 
suggesting involvement of the classical pathway of C activation. Ultrafiltration 
studies indicated that the NF-provoked neutropenia-inducing factor has a mol 
wt in  the range  of 10,000-30,000,  and is  heat stable  (56°C). To analyze  the 
hypothesis that  C-induced neutrophil margination might be  consequent to 
increased cell adhesiveness to endothelial surfaces, the role of C in promoting 
granulocyte adherence was evaluated in vitro. Measured with a  plastic Petri 
dish assay, granulocyte adherence was significantly reduced in heat-inactivated 
(56°C) and hydrazine-treated plasma, but adherence promoting capacity was 
restored by mixing the two plasmas, or by adding purified C3 to hydrazine- 
treated plasma. After exposure to activated C, neutrophils showed significantly 
increased adhesiveness which was maintained when cells were resuspended in 
heat-inactivated  plasma,  but  progressively lost  when  resuspended in  fresh 
plasma. On the basis of  these results we conclude that granulocyte adhesiveness 
in vitro and margination in vivo are closely associated, C-dependent phenom- 
ena. 
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